Rowland I R, Davies M J
J Appl Toxicol. 1982 Dec;2(6):294-9. doi: 10.1002/jat.2550020606.
After a single oral dose of sodium [74As] arsenate to male Wistar rats, arsenic was rapidly absorbed and accumulated in the blood and to a lesser extent in the liver, kidneys, lungs and spleen. Within 1 h of dosing, arsenic was present in the blood, liver and spleen predominantly in the methylated forms (methylarsonic acid and dimethylarsinic acid), whereas in the lung and kidneys, approximately 50% was in the inorganic form. Intravenous injection of sodium [74As] arsenate resulted in a pattern of arsenic species in the blood and kidneys similar to that seen after oral administration, suggesting that the gut flora does not contribute significantly to biotransformation of arsenic in vivo. Analysis of the forms of arsenic in portal blood after administration of arsenate via the small intestine revealed a rapid reduction of arsenate to arsenite, followed by linear rates of production of methylarsonic acid and dimethylarsinic acid.
给雄性Wistar大鼠单次口服[74As]砷酸钠后,砷迅速被吸收并在血液中蓄积,在肝脏、肾脏、肺和脾脏中的蓄积程度较低。给药后1小时内,血液、肝脏和脾脏中的砷主要以甲基化形式(甲基胂酸和二甲基胂酸)存在,而在肺和肾脏中,约50%为无机形式。静脉注射[74As]砷酸钠后,血液和肾脏中的砷形态模式与口服给药后相似,这表明肠道菌群对体内砷的生物转化作用不大。通过小肠给予砷酸盐后,对门静脉血中砷的形态分析显示,砷酸盐迅速还原为亚砷酸盐,随后甲基胂酸和二甲基胂酸呈线性生成速率。